Charles V Pollack Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

2/2020	Contemporary NSTEMI management: the role of the hospitalist.
3/2012	Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.
12/2006	The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies.
9/2006	Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles V Pollack Research Topics

Disease

58	Hemorrhage 02/2024 - 06/2006
56	Acute Coronary Syndrome 01/2023 - 11/2002
21	ST Elevation Myocardial Infarction 03/2021 - 01/2004
20	Myocardial Infarction 10/2020 - 03/2003
13	Stroke (Strokes) 02/2024 - 11/2005
13	Thrombosis (Thrombus) 02/2024 - 01/2003
13	Non-ST Elevated Myocardial Infarction 01/2023 - 11/2003
13	Unstable Angina 02/2020 - 09/2005
11	Heart Failure 05/2024 - 05/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2002
7	Atrial Fibrillation 02/2024 - 09/2013
7	Asthma (Bronchial Asthma) 01/2016 - 08/2002
6	Hypertension (High Blood Pressure) 10/2011 - 07/2006
5	Chronic Renal Insufficiency 05/2024 - 03/2008
5	Venous Thromboembolism 01/2019 - 11/2012
5	Ischemia 12/2009 - 12/2006
5	Chest Pain (Chest Pains) 12/2006 - 01/2004
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2020 - 09/2006
4	Necrosis 02/2020 - 04/2005
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 03/2014
4	Wounds and Injuries (Trauma) 04/2016 - 11/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 06/2011
3	Renal Insufficiency (Renal Failure) 02/2024 - 07/2002
3	Hyperkalemia 02/2023 - 01/2023
3	Pain (Aches) 01/2021 - 01/2015
2	COVID-19 01/2022 - 01/2020
2	Acute Pain 01/2021 - 03/2016
2	Infections 01/2020 - 04/2015
2	Ischemic Stroke 04/2016 - 01/2003
2	Musculoskeletal Pain 10/2015 - 01/2015
2	Hematoma 08/2014 - 12/2009
2	Pulmonary Embolism 09/2013 - 11/2012
2	Infarction (Infarctions) 05/2007 - 12/2006
2	Bundle-Branch Block (Fascicular Block) 10/2004 - 03/2003
2	Craniocerebral Trauma (Head Injury) 08/2003 - 11/2002
2	Closed Head Injuries 08/2003 - 11/2002

Drug/Important Bio-Agent (IBA)

21	AnticoagulantsIBA 02/2024 - 11/2012
17	Heparin (Liquaemin)FDA LinkGeneric 03/2021 - 06/2006
14	Clopidogrel (Plavix)FDA Link 12/2020 - 01/2003
14	Dabigatran FDA Link 10/2019 - 11/2012
12	Glycoproteins (Glycoprotein)IBA 03/2012 - 07/2003
10	TroponinIBA 02/2020 - 07/2002
9	Vitamin K FDA Link 02/2024 - 08/2014
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2003
9	idarucizumabIBA 01/2019 - 07/2015
8	Enoxaparin (Lovenox)FDA LinkGeneric 01/2017 - 10/2006
7	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2006
7	Platelet Membrane Glycoprotein IIbIBA 08/2009 - 07/2003
6	otamixabanIBA 01/2023 - 12/2012
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2016 - 06/2006
6	bivalirudin (Angiomax)FDA Link 08/2009 - 04/2008
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 09/2006
5	TicagrelorIBA 03/2022 - 11/2010
5	AntithrombinsIBA 09/2013 - 10/2006
4	Eptifibatide (Integrilin)FDA Link 03/2021 - 12/2012
4	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 09/2013
4	RivaroxabanIBA 01/2016 - 11/2012
3	sodium zirconium cyclosilicateIBA 05/2024 - 01/2023
3	Troleandomycin (TAO)FDA Link 01/2023 - 09/2013
3	Oxygen (Dioxygen)IBA 02/2020 - 03/2003
3	trans-crotonin (CTN)IBA 02/2020 - 12/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2012 - 08/2002
3	clevidipine FDA Link 04/2011 - 03/2009
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 02/2024 - 09/2020
2	Prasugrel Hydrochloride FDA Link 12/2020 - 02/2020
2	Complement System Proteins (Complement)IBA 09/2020 - 04/2009
2	Adenosine Diphosphate (ADP)IBA 02/2020 - 08/2009
2	prothrombin complex concentrates (PPSB)IBA 01/2020 - 08/2014
2	apixabanIBA 01/2018 - 09/2016
2	Purinergic P2Y Receptor AntagonistsIBA 06/2017 - 01/2003
2	Opioid Analgesics (Opioids)IBA 03/2016 - 10/2015
2	Analgesics (Analgesic Drugs)IBA 03/2016 - 01/2015
2	Hemoglobins (Hemoglobin)IBA 03/2014 - 06/2013
2	Factor Xa InhibitorsIBA 09/2013 - 05/2008
2	LipidsIBA 12/2010 - 07/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2010 - 07/2006
2	cangrelorIBA 12/2009 - 12/2009
2	Fondaparinux (Arixtra)FDA Link 06/2009 - 05/2008
2	helioxIBA 11/2008 - 03/2003
2	HeliumIBA 11/2008 - 03/2003
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2008 - 01/2004
2	Indicators and Reagents (Reagents)IBA 08/2007 - 01/2006
2	MB Form Creatine KinaseIBA 01/2006 - 01/2004
2	NexusIBA 08/2003 - 11/2002
2	Troponin T (Troponin T1)IBA 03/2003 - 07/2002
1	PotassiumIBA 05/2024
1	Therapeutic UsesIBA 02/2024

Therapy/Procedure

60	Therapeutics 05/2024 - 08/2002
19	Percutaneous Coronary Intervention 01/2023 - 03/2003
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2020 - 03/2003
4	Stents 12/2020 - 12/2009
3	Anticoagulation Reversal 10/2020 - 05/2017
3	Thrombolytic Therapy 01/2006 - 01/2004
2	Length of Stay 12/2020 - 11/2007
2	Electric Countershock (Cardioversion) 01/2018 - 09/2016
2	Analgesia 03/2016 - 01/2015
2	Catheters 06/2011 - 06/2009
2	Contraindications 05/2010 - 07/2005
1	Polypharmacy 02/2024
1	Ambulatory Care (Outpatient Care) 02/2023